Re-evaluating the clinical utility of a universal albumin cutoff for anastomotic leak risk stratification

To the Editor, We read with great interest the meta-analysis by Tang et al[1] investigating the relationship between preoperative albumin levels and anastomotic leakage risk. While the identification of a 3.75 g/dL threshold represents a valuable contribution to risk stratification, several methodological aspects warrant further consideration to ensure robust clinical translation. This correspondence was developed in accordance with the TITAN guideline for transparent reporting[2] The diagnostic performance characteristics of the proposed cutoff raise important clinical considerations. Although the threshold demonstrates high specificity (1.0), its limited sensitivity (0.55) and modest discriminative capacity ([area under the curve] AUC 0.69) indicate significant limitations in clinical utility. In prediction model methodology, an AUC below 0.7 generally indicates poor to modest discriminative ability[3]. This translates to a concerning false-negative rate where nearly half of patients developing anastomotic leaks would be misclassified as low risk. From a clinical implementation perspective, this degree of under-detection poses substantial patient safety concerns, particularly in postoperative monitoring protocols where early leak detection is critical. The pathophysiological interpretation of hypoalbuminemia in surgical risk prediction requires careful consideration. Current evidence suggests serum albumin functions primarily as a negative acute-phase reactant rather than solely as a nutritional marker[4]. This distinction carries significant implications for interventional strategies. If hypoalbuminemia predominantly reflects underlying systemic inflammation, then albumin supplementation alone may not address the fundamental pathophysiology driving impaired anastomotic healing. This concept is supported by recent evidence demonstrating that composite inflammatory-nutritional indices, such as the Nutrition-CRP Ratio, provide superior prognostic value compared to albumin alone in predicting clinical outcomes[5]. Furthermore, the assumption of a universal threshold across diverse surgical sites merits re-examination. The original meta-analysis revealed heterogeneous effect sizes across anatomical locations[1], with esophageal procedures demonstrating stronger associations (OR 2.82) compared to colorectal surgeries (OR 2.61). This variability suggests that site-specific physiological considerations – including tissue perfusion characteristics, anastomotic tension, and surgical complexity – may necessitate distinct risk stratification thresholds. Future research directions should prioritize two key objectives: first, validating the 3.75 g/dL threshold within specific surgical contexts rather than across all digestive tract surgeries; second, development of integrated prediction models that incorporate albumin within multidimensional frameworks including inflammatory markers, functional capacity measures, and procedure-specific risk factors[6]. Such approaches would better reflect the multifactorial nature of anastomotic healing while maintaining clinical feasibility.